Nonrandom cytogenetic changes in New Zealand patients with acute myeloid leukemia

Cancer Genet Cytogenet. 1983 Jan;8(1):51-66. doi: 10.1016/0165-4608(83)90064-x.

Abstract

Bone marrow clones with abnormal chromosomes were observed in 56% of 66 patients with forms of acute myeloid leukemia [French-American-British (FAB) M1-M6]. Acute myeloblastic leukemia (AML, M1 and M2) was the most common form, and 65% of these patients showed chromosomal abnormalities compared with 41% of patients with acute myelomonocytic leukemia (AMMoL, M4). The recognized nonrandom chromosomal abnormalities found were trisomy 8, monosomy 5 or 7, trisomy 1q, t(6;9), t(8;21), t(15;17), and abnormalities in 17q. There was also a strong involvement of chromosome No. 11: Abnormalities were found in eight patients when their leukemia was diagnosed and in a further three patients during the course of karyotypic evolution. Six of these patients had AMMoL or AMoL. Complex or multiple clones were found in 37% of AML patients at diagnosis. Our AML patients had a reduced frequency of abnormalities in chromosome No. 5 or 7 and an increased frequency of abnormalities in chromosome No. 8 compared with studies reported in other countries (p = 0.01). This difference suggests that in New Zealand AML might be caused by factors different from those operating in more industrialized centers.

MeSH terms

  • Bone Marrow / ultrastructure*
  • Chromosome Aberrations*
  • Chromosome Banding
  • Female
  • Humans
  • Karyotyping
  • Leukemia, Erythroblastic, Acute / genetics
  • Leukemia, Monocytic, Acute / genetics
  • Leukemia, Myeloid, Acute / genetics*
  • Male
  • Middle Aged
  • New Zealand